Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases » Hearing Disorders » Hearing Loss
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss
Description
A general term for the complete or partial loss of the ability to hear from one or both ears. MeSH
Hierarchy View
Subtype Terms (9)
Deafness
3 drugs (2 approved, 1 experimental)
Hearing Loss, Conductive
1 approved drug
Hearing Loss, Sensorineural
38 drugs (21 approved, 17 experimental)
Hearing Loss, Sudden
11 drugs (6 approved, 5 experimental)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (9)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (16)
Organization Involved with Phase 2 Indications (33)
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (16)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
